Safety of Concurrent Boston Type I Keratoprosthesis and Glaucoma Drainage Device Implantation

To evaluate the safety of concurrent Boston type I keratoprosthesis (KPro) and glaucoma drainage device (GDD) implantation. Retrospective comparative study of a consecutive cohort of patients. Patients who underwent KPro implantation by a single surgeon (A.J.A.) with or without 1 concurrent Ahmed GD...

Full description

Saved in:
Bibliographic Details
Published inOphthalmology (Rochester, Minn.) Vol. 124; no. 1; pp. 12 - 19
Main Authors Lenis, Tamara L., Chiu, Stephan Y., Law, Simon K., Yu, Fei, Aldave, Anthony J.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2017
Subjects
Online AccessGet full text
ISSN0161-6420
1549-4713
1549-4713
DOI10.1016/j.ophtha.2016.08.003

Cover

Loading…
Abstract To evaluate the safety of concurrent Boston type I keratoprosthesis (KPro) and glaucoma drainage device (GDD) implantation. Retrospective comparative study of a consecutive cohort of patients. Patients who underwent KPro implantation by a single surgeon (A.J.A.) with or without 1 concurrent Ahmed GDD (New World Medical, Inc., Rancho Cucamonga, CA) implantation between January 1, 2005, and January 31, 2015, were included. Patients with fewer than 3 months of follow-up or a history of previous KPro implantation were excluded. Preoperative, operative, and postoperative data were collected for each procedure. All comparisons were made between KPro procedures performed with or without concurrent GDD implantation. The Fisher exact test (2-tailed) was used to compare proportions, Student t test and Wilcoxon rank-sum test were used to compare means, and the log-rank test was used to compare time-to-outcome events. The primary outcome was frequency of the composite variable, that is, any serious vision-threatening postoperative complication, which included sterile vitreitis, endophthalmitis, hypotony maculopathy, suprachoroidal hemorrhage, retinal detachment, stromal necrosis, and infectious keratitis. Secondary outcomes included intraocular pressure control, worsening of visual acuity, cystoid macular edema, retroprosthetic membrane formation, persistent epithelial defect formation, GDD exposure, and KPro removal. One hundred thirty-seven KPro procedures were performed in 129 patients: 91 (66.4%) KPro alone and 46 (33.6%) KPro plus GDD. There were no statistically significant differences between the 2 groups in terms of the incidence of vision-threatening postoperative complications. None of the 46 GDDs placed at the same time as the KPro became exposed during an average follow-up of 44 months. Compared with KPro alone, GDD placement combined with KPro was not associated with increased postoperative complications.
AbstractList To evaluate the safety of concurrent Boston type I keratoprosthesis (KPro) and glaucoma drainage device (GDD) implantation. Retrospective comparative study of a consecutive cohort of patients. Patients who underwent KPro implantation by a single surgeon (A.J.A.) with or without 1 concurrent Ahmed GDD (New World Medical, Inc., Rancho Cucamonga, CA) implantation between January 1, 2005, and January 31, 2015, were included. Patients with fewer than 3 months of follow-up or a history of previous KPro implantation were excluded. Preoperative, operative, and postoperative data were collected for each procedure. All comparisons were made between KPro procedures performed with or without concurrent GDD implantation. The Fisher exact test (2-tailed) was used to compare proportions, Student t test and Wilcoxon rank-sum test were used to compare means, and the log-rank test was used to compare time-to-outcome events. The primary outcome was frequency of the composite variable, that is, any serious vision-threatening postoperative complication, which included sterile vitreitis, endophthalmitis, hypotony maculopathy, suprachoroidal hemorrhage, retinal detachment, stromal necrosis, and infectious keratitis. Secondary outcomes included intraocular pressure control, worsening of visual acuity, cystoid macular edema, retroprosthetic membrane formation, persistent epithelial defect formation, GDD exposure, and KPro removal. One hundred thirty-seven KPro procedures were performed in 129 patients: 91 (66.4%) KPro alone and 46 (33.6%) KPro plus GDD. There were no statistically significant differences between the 2 groups in terms of the incidence of vision-threatening postoperative complications. None of the 46 GDDs placed at the same time as the KPro became exposed during an average follow-up of 44 months. Compared with KPro alone, GDD placement combined with KPro was not associated with increased postoperative complications.
To evaluate the safety of concurrent Boston type I keratoprosthesis (KPro) and glaucoma drainage device (GDD) implantation.PURPOSETo evaluate the safety of concurrent Boston type I keratoprosthesis (KPro) and glaucoma drainage device (GDD) implantation.Retrospective comparative study of a consecutive cohort of patients.DESIGNRetrospective comparative study of a consecutive cohort of patients.Patients who underwent KPro implantation by a single surgeon (A.J.A.) with or without 1 concurrent Ahmed GDD (New World Medical, Inc., Rancho Cucamonga, CA) implantation between January 1, 2005, and January 31, 2015, were included. Patients with fewer than 3 months of follow-up or a history of previous KPro implantation were excluded.SUBJECTSPatients who underwent KPro implantation by a single surgeon (A.J.A.) with or without 1 concurrent Ahmed GDD (New World Medical, Inc., Rancho Cucamonga, CA) implantation between January 1, 2005, and January 31, 2015, were included. Patients with fewer than 3 months of follow-up or a history of previous KPro implantation were excluded.Preoperative, operative, and postoperative data were collected for each procedure. All comparisons were made between KPro procedures performed with or without concurrent GDD implantation. The Fisher exact test (2-tailed) was used to compare proportions, Student t test and Wilcoxon rank-sum test were used to compare means, and the log-rank test was used to compare time-to-outcome events.METHODSPreoperative, operative, and postoperative data were collected for each procedure. All comparisons were made between KPro procedures performed with or without concurrent GDD implantation. The Fisher exact test (2-tailed) was used to compare proportions, Student t test and Wilcoxon rank-sum test were used to compare means, and the log-rank test was used to compare time-to-outcome events.The primary outcome was frequency of the composite variable, that is, any serious vision-threatening postoperative complication, which included sterile vitreitis, endophthalmitis, hypotony maculopathy, suprachoroidal hemorrhage, retinal detachment, stromal necrosis, and infectious keratitis. Secondary outcomes included intraocular pressure control, worsening of visual acuity, cystoid macular edema, retroprosthetic membrane formation, persistent epithelial defect formation, GDD exposure, and KPro removal.MAIN OUTCOME MEASURESThe primary outcome was frequency of the composite variable, that is, any serious vision-threatening postoperative complication, which included sterile vitreitis, endophthalmitis, hypotony maculopathy, suprachoroidal hemorrhage, retinal detachment, stromal necrosis, and infectious keratitis. Secondary outcomes included intraocular pressure control, worsening of visual acuity, cystoid macular edema, retroprosthetic membrane formation, persistent epithelial defect formation, GDD exposure, and KPro removal.One hundred thirty-seven KPro procedures were performed in 129 patients: 91 (66.4%) KPro alone and 46 (33.6%) KPro plus GDD. There were no statistically significant differences between the 2 groups in terms of the incidence of vision-threatening postoperative complications. None of the 46 GDDs placed at the same time as the KPro became exposed during an average follow-up of 44 months.RESULTSOne hundred thirty-seven KPro procedures were performed in 129 patients: 91 (66.4%) KPro alone and 46 (33.6%) KPro plus GDD. There were no statistically significant differences between the 2 groups in terms of the incidence of vision-threatening postoperative complications. None of the 46 GDDs placed at the same time as the KPro became exposed during an average follow-up of 44 months.Compared with KPro alone, GDD placement combined with KPro was not associated with increased postoperative complications.CONCLUSIONSCompared with KPro alone, GDD placement combined with KPro was not associated with increased postoperative complications.
Purpose To evaluate the safety of concurrent Boston type I keratoprosthesis (KPro) and glaucoma drainage device (GDD) implantation. Design Retrospective comparative study of a consecutive cohort of patients. Subjects Patients who underwent KPro implantation by a single surgeon (A.J.A.) with or without 1 concurrent Ahmed GDD (New World Medical, Inc., Rancho Cucamonga, CA) implantation between January 1, 2005, and January 31, 2015, were included. Patients with fewer than 3 months of follow-up or a history of previous KPro implantation were excluded. Methods Preoperative, operative, and postoperative data were collected for each procedure. All comparisons were made between KPro procedures performed with or without concurrent GDD implantation. The Fisher exact test (2-tailed) was used to compare proportions, Student t test and Wilcoxon rank-sum test were used to compare means, and the log-rank test was used to compare time-to-outcome events. Main Outcome Measures The primary outcome was frequency of the composite variable, that is, any serious vision-threatening postoperative complication, which included sterile vitreitis, endophthalmitis, hypotony maculopathy, suprachoroidal hemorrhage, retinal detachment, stromal necrosis, and infectious keratitis. Secondary outcomes included intraocular pressure control, worsening of visual acuity, cystoid macular edema, retroprosthetic membrane formation, persistent epithelial defect formation, GDD exposure, and KPro removal. Results One hundred thirty-seven KPro procedures were performed in 129 patients: 91 (66.4%) KPro alone and 46 (33.6%) KPro plus GDD. There were no statistically significant differences between the 2 groups in terms of the incidence of vision-threatening postoperative complications. None of the 46 GDDs placed at the same time as the KPro became exposed during an average follow-up of 44 months. Conclusions Compared with KPro alone, GDD placement combined with KPro was not associated with increased postoperative complications.
Author Law, Simon K.
Aldave, Anthony J.
Lenis, Tamara L.
Chiu, Stephan Y.
Yu, Fei
Author_xml – sequence: 1
  givenname: Tamara L.
  surname: Lenis
  fullname: Lenis, Tamara L.
  organization: Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles
– sequence: 2
  givenname: Stephan Y.
  surname: Chiu
  fullname: Chiu, Stephan Y.
  organization: Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles
– sequence: 3
  givenname: Simon K.
  surname: Law
  fullname: Law, Simon K.
  organization: Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles
– sequence: 4
  givenname: Fei
  surname: Yu
  fullname: Yu, Fei
  organization: Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles
– sequence: 5
  givenname: Anthony J.
  surname: Aldave
  fullname: Aldave, Anthony J.
  email: Aldave@jsei.ucla.edu
  organization: Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27614591$$D View this record in MEDLINE/PubMed
BookMark eNqVUsFu1DAQtVAR3Rb-ACEfuSTYceIkCCHBFkpFJQ4tR2R5JxPWS2IH26m0f4-jtBckVHEa2X7vzbznOSMn1lkk5CVnOWdcvjnkbtrHvc6LdMpZkzMmnpANr8o2K2suTsgmPfBMlgU7JWchHBhjUoryGTktasnLquUb8uNG9xiP1PV06yzM3qON9KML0Vl6e5yQXtGv6HV0k0-XewwmUG07ejnoGdyo6YXXxuqfSC_wzkDCj9OgbdTROPucPO31EPDFfT0n3z9_ut1-ya6_XV5tP1xnUNYsZo1OAzNgrdhpLUTFodFtI3qZap08dHUBDbRQyb7vJe5qhqgFgCh3TYnYinPyetVNQ_6eMUQ1mgA4pEHQzUHxpuJFXVR8gb66h867ETs1eTNqf1QPkSTA2xUAyXDw2Cswq5uYnA6KM7Xkrw5qzV8t-SvWqJR_Ipd_kR_0H6G9X2mYQroz6FUAgxawMx4hqs6Z_xWAwVgDeviFRwwHN3ubPkBxFQrF1M2yGcticClYLesllnf_Fni8_x-eTcsP
CitedBy_id crossref_primary_10_1097_ICO_0000000000001983
crossref_primary_10_1177_0391398818762349
crossref_primary_10_53432_2078_4104_2024_23_4_29_35
crossref_primary_10_1016_j_survophthal_2022_01_005
crossref_primary_10_1097_ICO_0000000000002996
crossref_primary_10_1097_ICO_0000000000001405
crossref_primary_10_1097_ICU_0000000000000373
crossref_primary_10_1097_ICU_0000000000000572
crossref_primary_10_1016_j_ajo_2021_09_005
crossref_primary_10_1177_2515841419868559
crossref_primary_10_1016_j_ajo_2019_11_003
crossref_primary_10_1016_j_ajo_2019_03_016
crossref_primary_10_1007_s40123_021_00446_y
crossref_primary_10_1371_journal_pone_0192381
crossref_primary_10_1016_j_jtos_2020_11_010
crossref_primary_10_1111_aos_15292
crossref_primary_10_1097_ICO_0000000000001618
crossref_primary_10_1097_ICO_0000000000003819
crossref_primary_10_1097_IJG_0000000000001723
crossref_primary_10_1167_tvst_11_8_14
crossref_primary_10_1007_s00417_024_06445_6
crossref_primary_10_1097_ICO_0000000000002986
crossref_primary_10_1007_s40123_019_0186_6
crossref_primary_10_1097_ICO_0000000000002962
crossref_primary_10_1016_j_jfo_2023_05_031
crossref_primary_10_1097_ICO_0000000000001735
crossref_primary_10_1097_ICO_0000000000002649
crossref_primary_10_1002_jbio_201900098
crossref_primary_10_1080_17469899_2020_1809378
crossref_primary_10_1097_ICO_0000000000002883
crossref_primary_10_1097_IAE_0000000000003233
crossref_primary_10_2147_OPTH_S349719
crossref_primary_10_1089_ten_tea_2022_29025_abstracts
crossref_primary_10_1016_j_survophthal_2017_09_003
crossref_primary_10_1016_j_ophtha_2016_10_012
crossref_primary_10_2147_OPTH_S219270
crossref_primary_10_1097_ICU_0000000000000924
Cites_doi 10.1016/j.ophtha.2012.02.015
10.1016/j.ajo.2011.09.005
10.1097/ICO.0b013e31820f7a32
10.1016/j.ophtha.2006.05.015
10.1016/j.ajo.2011.07.022
10.1016/j.ophtha.2004.02.003
10.1016/j.ajo.2011.07.014
10.1016/j.ajo.2011.01.034
10.1097/ICO.0000000000000067
10.1016/j.ophtha.2008.12.058
10.1016/j.ajo.2012.02.033
10.1097/IJG.0b013e31829d9c00
10.1097/ICO.0b013e3181a186dc
10.1016/S0161-6420(98)94034-9
10.1016/j.ophtha.2008.03.031
10.1136/bjophthalmol-2012-302770
10.1016/j.ophtha.2014.05.030
ContentType Journal Article
Copyright 2016 American Academy of Ophthalmology
American Academy of Ophthalmology
Copyright © 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2016 American Academy of Ophthalmology
– notice: American Academy of Ophthalmology
– notice: Copyright © 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.ophtha.2016.08.003
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1549-4713
EndPage 19
ExternalDocumentID 27614591
10_1016_j_ophtha_2016_08_003
S0161642016307679
1_s2_0_S0161642016307679
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
123
1B1
1CY
1P~
1~5
29N
4.4
457
4G.
53G
5RE
5VS
7-5
71M
AAEDT
AAEDW
AALRI
AAQFI
AAQQT
AAQXK
AAXUO
ABCQX
ABFRF
ABJNI
ABLJU
ABMAC
ABOCM
ABWVN
ACGFO
ACGFS
ACIUM
ACNCT
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEFWE
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AGCQF
AGQPQ
AIGII
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BELOY
C5W
CS3
DU5
EBS
EFJIC
EFKBS
EJD
F5P
FDB
FEDTE
FGOYB
GBLVA
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M27
M41
MO0
N4W
N9A
NQ-
O9-
OF-
OPF
OQ~
P2P
R2-
ROL
RPZ
SDG
SEL
SES
SSZ
UHS
UNMZH
UV1
WH7
X7M
XH2
XPP
Z5R
ZGI
ZXP
ADPAM
RIG
AAIAV
AGZHU
AHPSJ
ALXNB
ZA5
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c470t-8a4710c093baa3351c8a983f6c8a7161d72c8c9c56fff6eb70eea3cc34b84ee93
ISSN 0161-6420
1549-4713
IngestDate Fri Jul 11 01:50:18 EDT 2025
Thu Jan 02 23:12:23 EST 2025
Tue Jul 01 00:44:07 EDT 2025
Thu Apr 24 23:07:48 EDT 2025
Fri Feb 23 02:28:31 EST 2024
Tue Feb 25 20:09:28 EST 2025
Tue Aug 26 16:37:05 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords KPro
CDVA
IOP
LP
logMAR
GDD
light perception
corrected distance visual acuity
intraocular pressure
glaucoma drainage device
Boston type I keratoprosthesis
logarithm of the minimum angle of resolution
Language English
License Copyright © 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c470t-8a4710c093baa3351c8a983f6c8a7161d72c8c9c56fff6eb70eea3cc34b84ee93
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 27614591
PQID 1851272519
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1851272519
pubmed_primary_27614591
crossref_citationtrail_10_1016_j_ophtha_2016_08_003
crossref_primary_10_1016_j_ophtha_2016_08_003
elsevier_sciencedirect_doi_10_1016_j_ophtha_2016_08_003
elsevier_clinicalkeyesjournals_1_s2_0_S0161642016307679
elsevier_clinicalkey_doi_10_1016_j_ophtha_2016_08_003
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-01-01
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Ophthalmology (Rochester, Minn.)
PublicationTitleAlternate Ophthalmology
PublicationYear 2017
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Netland, Terada, Dohlman (bib6) 1998; 105
Minckler, Francis, Hodapp (bib8) 2008; 115
Crnej, Paschalis, Salvador-Culla (bib7) 2014; 33
Globe, Wu, Azen, Varma (bib12) 2004; 111
Kamyar, Weizer, de Paula (bib15) 2012; 31
Patel, Takusagawa, Shen (bib17) 2012; 154
Aldave, Sangwan, Basu (bib5) 2012; 119
Robert, Pomerleau, Harissi-Dagher (bib10) 2013; 97
Srikumaran, Munoz, Aldave (bib1) 2014; 121
Talajic, Agoumi, Gagne (bib9) 2012; 153
(bib11) 2003
Law, Huang, Nassiri (bib13) 2014; 23
Zerbe, Belin, Ciolino (bib2) 2006; 113
Moussally, Harissi-Dagher (bib16) 2011; 152
Chew, Ayres, Hammersmith (bib4) 2009; 28
Li, Greiner, Brandt (bib3) 2011; 152
Aldave, Kamal, Vo, Yu (bib14) 2009; 116
Cortina, Vajaranant, de la Cruz (bib18) 2011; 152
Minckler (10.1016/j.ophtha.2016.08.003_bib8) 2008; 115
Kamyar (10.1016/j.ophtha.2016.08.003_bib15) 2012; 31
Srikumaran (10.1016/j.ophtha.2016.08.003_bib1) 2014; 121
Moussally (10.1016/j.ophtha.2016.08.003_bib16) 2011; 152
Zerbe (10.1016/j.ophtha.2016.08.003_bib2) 2006; 113
Globe (10.1016/j.ophtha.2016.08.003_bib12) 2004; 111
Robert (10.1016/j.ophtha.2016.08.003_bib10) 2013; 97
Law (10.1016/j.ophtha.2016.08.003_bib13) 2014; 23
Cortina (10.1016/j.ophtha.2016.08.003_bib18) 2011; 152
Talajic (10.1016/j.ophtha.2016.08.003_bib9) 2012; 153
Patel (10.1016/j.ophtha.2016.08.003_bib17) 2012; 154
Li (10.1016/j.ophtha.2016.08.003_bib3) 2011; 152
Aldave (10.1016/j.ophtha.2016.08.003_bib5) 2012; 119
Netland (10.1016/j.ophtha.2016.08.003_bib6) 1998; 105
Chew (10.1016/j.ophtha.2016.08.003_bib4) 2009; 28
Aldave (10.1016/j.ophtha.2016.08.003_bib14) 2009; 116
Crnej (10.1016/j.ophtha.2016.08.003_bib7) 2014; 33
(10.1016/j.ophtha.2016.08.003_bib11) 2003
27993268 - Ophthalmology. 2017 Jan;124(1):9-11
References_xml – volume: 111
  start-page: 1141
  year: 2004
  end-page: 1149
  ident: bib12
  article-title: The impact of visual impairment on self-reported visual functioning in Latinos: the Los Angeles Latino Eye Study
  publication-title: Ophthalmology
– volume: 154
  start-page: 207
  year: 2012
  end-page: 208
  ident: bib17
  article-title: Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis
  publication-title: Am J Ophthalmol
– volume: 152
  start-page: 883
  year: 2011
  end-page: 884
  ident: bib16
  article-title: Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis
  publication-title: Am J Ophthalmol
– volume: 115
  start-page: 1089
  year: 2008
  end-page: 1098
  ident: bib8
  article-title: Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology
  publication-title: Ophthalmology
– volume: 113
  start-page: 1779.e1
  year: 2006
  end-page: 1779.e7
  ident: bib2
  article-title: Results from the multicenter Boston Type 1 Keratoprosthesis Study
  publication-title: Ophthalmology
– volume: 33
  start-page: 349
  year: 2014
  end-page: 354
  ident: bib7
  article-title: Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis
  publication-title: Cornea
– volume: 31
  start-page: 134
  year: 2012
  end-page: 139
  ident: bib15
  article-title: Glaucoma associated with Boston type I keratoprosthesis
  publication-title: Cornea
– volume: 152
  start-page: 1078
  year: 2011
  end-page: 1079
  ident: bib18
  article-title: Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis
  publication-title: Am J Ophthalmol
– volume: 28
  start-page: 989
  year: 2009
  end-page: 996
  ident: bib4
  article-title: Boston keratoprosthesis outcomes and complications
  publication-title: Cornea
– volume: 23
  start-page: 501
  year: 2014
  end-page: 507
  ident: bib13
  article-title: Technique of combined glaucoma tube shunt and keratoprosthesis implantation
  publication-title: J Glaucoma
– year: 2003
  ident: bib11
  article-title: Consultation on development of standards for characterization of vision loss and visual functioning. Geneva, 4–5 September 2003
– volume: 105
  start-page: 751
  year: 1998
  end-page: 757
  ident: bib6
  article-title: Glaucoma associated with keratoprosthesis
  publication-title: Ophthalmology
– volume: 153
  start-page: 267
  year: 2012
  end-page: 274.e1
  ident: bib9
  article-title: Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery
  publication-title: Am J Ophthalmol
– volume: 97
  start-page: 573
  year: 2013
  end-page: 577
  ident: bib10
  article-title: Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices
  publication-title: Br J Ophthalmol
– volume: 119
  start-page: 1530
  year: 2012
  end-page: 1538
  ident: bib5
  article-title: International results with the Boston type I keratoprosthesis
  publication-title: Ophthalmology
– volume: 152
  start-page: 209
  year: 2011
  end-page: 218
  ident: bib3
  article-title: Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis
  publication-title: Am J Ophthalmol
– volume: 116
  start-page: 640
  year: 2009
  end-page: 651
  ident: bib14
  article-title: The Boston type I keratoprosthesis: improving outcomes and expanding indications
  publication-title: Ophthalmology
– volume: 121
  start-page: 2159
  year: 2014
  end-page: 2164
  ident: bib1
  article-title: Long-term outcomes of Boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort
  publication-title: Ophthalmology
– volume: 119
  start-page: 1530
  issue: 8
  year: 2012
  ident: 10.1016/j.ophtha.2016.08.003_bib5
  article-title: International results with the Boston type I keratoprosthesis
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2012.02.015
– year: 2003
  ident: 10.1016/j.ophtha.2016.08.003_bib11
– volume: 152
  start-page: 1078
  issue: 6
  year: 2011
  ident: 10.1016/j.ophtha.2016.08.003_bib18
  article-title: Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2011.09.005
– volume: 31
  start-page: 134
  issue: 2
  year: 2012
  ident: 10.1016/j.ophtha.2016.08.003_bib15
  article-title: Glaucoma associated with Boston type I keratoprosthesis
  publication-title: Cornea
  doi: 10.1097/ICO.0b013e31820f7a32
– volume: 113
  start-page: 1779.e1
  issue: 10
  year: 2006
  ident: 10.1016/j.ophtha.2016.08.003_bib2
  article-title: Results from the multicenter Boston Type 1 Keratoprosthesis Study
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2006.05.015
– volume: 153
  start-page: 267
  issue: 2
  year: 2012
  ident: 10.1016/j.ophtha.2016.08.003_bib9
  article-title: Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2011.07.022
– volume: 111
  start-page: 1141
  issue: 6
  year: 2004
  ident: 10.1016/j.ophtha.2016.08.003_bib12
  article-title: The impact of visual impairment on self-reported visual functioning in Latinos: the Los Angeles Latino Eye Study
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2004.02.003
– volume: 152
  start-page: 883
  issue: 5
  year: 2011
  ident: 10.1016/j.ophtha.2016.08.003_bib16
  article-title: Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2011.07.014
– volume: 152
  start-page: 209
  issue: 2
  year: 2011
  ident: 10.1016/j.ophtha.2016.08.003_bib3
  article-title: Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2011.01.034
– volume: 33
  start-page: 349
  issue: 4
  year: 2014
  ident: 10.1016/j.ophtha.2016.08.003_bib7
  article-title: Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis
  publication-title: Cornea
  doi: 10.1097/ICO.0000000000000067
– volume: 116
  start-page: 640
  issue: 4
  year: 2009
  ident: 10.1016/j.ophtha.2016.08.003_bib14
  article-title: The Boston type I keratoprosthesis: improving outcomes and expanding indications
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2008.12.058
– volume: 154
  start-page: 207
  issue: 1
  year: 2012
  ident: 10.1016/j.ophtha.2016.08.003_bib17
  article-title: Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2012.02.033
– volume: 23
  start-page: 501
  issue: 8
  year: 2014
  ident: 10.1016/j.ophtha.2016.08.003_bib13
  article-title: Technique of combined glaucoma tube shunt and keratoprosthesis implantation
  publication-title: J Glaucoma
  doi: 10.1097/IJG.0b013e31829d9c00
– volume: 28
  start-page: 989
  issue: 9
  year: 2009
  ident: 10.1016/j.ophtha.2016.08.003_bib4
  article-title: Boston keratoprosthesis outcomes and complications
  publication-title: Cornea
  doi: 10.1097/ICO.0b013e3181a186dc
– volume: 105
  start-page: 751
  issue: 4
  year: 1998
  ident: 10.1016/j.ophtha.2016.08.003_bib6
  article-title: Glaucoma associated with keratoprosthesis
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(98)94034-9
– volume: 115
  start-page: 1089
  issue: 6
  year: 2008
  ident: 10.1016/j.ophtha.2016.08.003_bib8
  article-title: Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2008.03.031
– volume: 97
  start-page: 573
  issue: 5
  year: 2013
  ident: 10.1016/j.ophtha.2016.08.003_bib10
  article-title: Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjophthalmol-2012-302770
– volume: 121
  start-page: 2159
  issue: 11
  year: 2014
  ident: 10.1016/j.ophtha.2016.08.003_bib1
  article-title: Long-term outcomes of Boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2014.05.030
– reference: 27993268 - Ophthalmology. 2017 Jan;124(1):9-11
SSID ssj0006634
Score 2.3999329
Snippet To evaluate the safety of concurrent Boston type I keratoprosthesis (KPro) and glaucoma drainage device (GDD) implantation. Retrospective comparative study of...
Purpose To evaluate the safety of concurrent Boston type I keratoprosthesis (KPro) and glaucoma drainage device (GDD) implantation. Design Retrospective...
To evaluate the safety of concurrent Boston type I keratoprosthesis (KPro) and glaucoma drainage device (GDD) implantation.PURPOSETo evaluate the safety of...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 12
SubjectTerms Adult
Aged
Artificial Organs
Corneal Diseases - surgery
Female
Glaucoma - surgery
Glaucoma Drainage Implants - adverse effects
Humans
Intraocular Pressure
Male
Middle Aged
Ophthalmology
Postoperative Complications
Prostheses and Implants - adverse effects
Prosthesis Implantation - adverse effects
Prosthesis Implantation - methods
Retrospective Studies
Title Safety of Concurrent Boston Type I Keratoprosthesis and Glaucoma Drainage Device Implantation
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0161642016307679
https://www.clinicalkey.es/playcontent/1-s2.0-S0161642016307679
https://dx.doi.org/10.1016/j.ophtha.2016.08.003
https://www.ncbi.nlm.nih.gov/pubmed/27614591
https://www.proquest.com/docview/1851272519
Volume 124
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9owELcYlaa9TPsu-5In7Q0ZOXE-Hzto1w7YpJVq7cNkOY4jWtEEFXjZ2_7znWMnRBTUri8BQs5xfL-c7853Z4Q-Z5FkAiZO4qaMEU8GMYmF45M48l3qiZSJMn1s_D04PvO-nfvnrdbfZnbJMunJP1vzSh7CVTgHfNVZsv_B2bpROAHfgb9wBA7D8V48PhWZshEVRS5tpSVbKkMbmN2T7lAXTS7mOrdjqnTxEe0o_zoTK-iP6A70BhE6amegtMQoawWLvLE6b9XWH_Ppcipm16ZgU-l1sBttmdD7PO81XAojlZvKBRNxLW5Ed1RKoHEdW9yfXq7qCDOQLxfl_19qtXQkzHoTwCjvDjeIL0rSI3Vp3EGDptvCCRtuC-vJDBwCxg_dKseNS-GqV5SPpyPwgrLSKmXreataqz_sDx2ycHuUnOpGdZugZNIwMLvUbJTTdvjC5ZTfuvQR2nPB0nDbaO9g-PPXsJ7OQSWzBeJNf6v8yzJI8Hb_duk3u-yXUo-ZPENPrQGCDwyanqOWyl-gx2MbYvES_TagwkWG16DCBlRYgwqf4E1QYQAVrkCFK1BhAyrcBNUrdHZ0OOkfE7sHB5FeSJckEqC9UEljlgjBmO_ISMQRywL4BFPbSUNXRjKWfpBlWaCSkColmJTMSyJPqZi9Ru28yNU-wlEC6nCWRmnix17qqoRJ-An2ve-w1FGig1g1clzaAvV6n5QZryIRr7gZb67Hm-vtUynrIFJTzU2Bljuu9yum8Cr5GKZLDsi7gy7cRqcWVh4s-C5kNSmtWmvU1Xvc81OFGg5SXy_liVwVK7gXGEpuqLPOO-iNgVP99G4IKrcfO28f3ON36Mn6lX2P2sublfoAuvcy-Wjfjn8hLtKc
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety+of+Concurrent+Boston+Type+I+Keratoprosthesis+and+Glaucoma+Drainage+Device+Implantation&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=Lenis%2C+Tamara+L.%2C+MD&rft.au=Chiu%2C+Stephan+Y.%2C+BS&rft.au=Law%2C+Simon+K.%2C+MD&rft.au=Yu%2C+Fei%2C+PhD&rft.date=2017-01-01&rft.issn=0161-6420&rft_id=info:doi/10.1016%2Fj.ophtha.2016.08.003&rft.externalDBID=ECK1-s2.0-S0161642016307679&rft.externalDocID=1_s2_0_S0161642016307679
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0161-6420&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0161-6420&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0161-6420&client=summon